Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and NeckGlenn J. Hanna, Robert I. Haddad, Vickie Y. Jo et al.|Clinical Cancer Research|2021Cited by 104
A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinomaGlenn J. Hanna, Robert I. Haddad, Anne O’Neill et al.|Oral Oncology|2021Cited by 51